137 research outputs found
N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
<p>Abstract</p> <p>Background</p> <p>N-terminal-pro-brain natriuretic peptide (NT-proBNP) is elevated in gestational hypertension and preeclampsia. This trial aimed to generate data for gestational diabetes mellitus patients, who are at risk to develop these complications.</p> <p>Methods</p> <p>We have measured NT-proBNP in 223 otherwise healthy women between gestational week 24 and 32 referred to the outpatient diabetes unit in a cross-sectional study.</p> <p>Results</p> <p>88 control subjects, 45 patients with indication for medical nutrition therapy (MNT) alone and 90 patients who required insulin therapy were included. Groups of women were comparable regarding gestational week. Body mass index before pregnancy and at blood draw was significantly higher in subjects with insulin dependent gestational diabetes mellitus compared to MNT controlled gestational diabetes mellitus. NT-proBNP was significantly lower in patients with insulin dependent gestational diabetes mellitus (35 ± 25 pg/ml) compared to controls (53 ± 43 pg/ml, p = 0.012).</p> <p>Conclusions</p> <p>NT-proBNP is within the reference range of normal subjects in women with gestational diabetes mellitus. Differences in body mass index, changes in glomerular filtration rate and haemodynamics may explain lower NT-proBNP concentrations in insulin dependent gestational diabetes mellitus. A false negative interpretation needs to be considered in these women.</p
Vascular morphometric changes after radioactivestent implantation: a dose-response analysis
AbstractObjectivesThe goal of this study was to evaluate the dose-dependency of morphometric changes in the coronary arterial wall after radioactive stenting.BackgroundRadioactive stents have been found to reduce intrastent intimal hyperplasia (IIH) but lead to a characteristic type of restenosis occurring predominantly at the stent edges.MethodsFifteen patients underwent intravascular ultrasound (IVUS) examination after implantation of a P-32 radioactive stent and at the six-month follow-up. The post-stent IVUS measurements on seven predefined locations of each lesion were subjected to a computer algorithm for the development of dose-volume histograms (DVH). Thus, we derived the radiation doses delivered to at least 10% and 90% of the adventitia (DV10, DV90). The IIH and vascular remodeling at follow-up were correlated with the doses in each segment.ResultsThe IIH was most pronounced at the stent edges and lowest in the stent-body, whereas we detected a significant expansive remodeling within the stent body. The delivered doses correlated with a decreased IIH (r = 0.52, p < 0.001 for DV10 and r = 0.62, p < 0.001 for DV90) and with expansive remodeling (r = 0.48, p = 0.009 for DV10 and r = 0.50, p = 0.006 for DV90). A DV10 >90 Gy or a DV90 >15 Gy reduced IIH and induced expansive remodeling. Plaque growth was not reduced by radioactive stents.ConclusionsThe DVH analysis reveals a dose-dependent increase of external elastic lamina area behind radioactive stents, whereas plaque growth is not reduced but inverted into an outward direction from the stent. A DV10 >90 Gy or a DV90 >15 Gy results in a beneficial long-term outcome after radioactive stenting
Bioimpedance cardiography in pregnancy: A longitudinal cohort study on hemodynamic pattern and outcome
Background: Pregnancy associated cardiovascular pathologies have a significant impact on outcome for mother
and child. Bioimpedance cardiography may provide additional outcome-relevant information early in pregnancy
and may also be used as a predictive instrument for pregnancy-associated diseases.
Methods: We performed a prospective longitudinal cohort trial in an outpatient setting and included 242 pregnant
women. Cardiac output and concomitant hemodynamic data were recorded from 11th-13th week of gestation
every 5th week as well as at two occasions post partum employing bioimpedance cardiography.
Results: Cardiac output increased during pregnancy and peaked early in the third trimester. A higher heart rate
and a decreased systemic vascular resistance were accountable for the observed changes. Women who had a
pregnancy-associated disease during a previous pregnancy or developed hypertension or preeclampsia had a
significantly increased cardiac output early in pregnancy. Furthermore, an effect of cardiac output on birthweight
was found in healthy pregnancies and could be confirmed with multiple linear regression analysis.
Conclusions: Cardiovascular adaptation during pregnancy is characterized by distinct pattern described herein.
These may be altered in women at risk for preeclampsia or reduced birthweigth. The assessment of cardiac
parameters by bioimpedance cardiography could be performed at low costs without additional risks
Significance of siteâspecific radiation dose and technique for success of implantâbased prosthetic rehabilitation in irradiated head and neck cancer patientsâA cohort study
Background
Radiotherapy aggravates implantâbased prosthetic rehabilitation in patients with head and neck cancer.
Purpose
To evaluate the impact of radiation dose at implant and parotid gland site for prosthetic rehabilitation.
Material and methods
The retrospective study includes 121 irradiated head and neck cancer patients with 751 inserted implants. Radiation doses on implant bed and parotid gland site were recorded by 3âdimensional modulated radiation plans. Implant success was clinically and radiographically evaluated according to modified Albrektsson criteria and compared to treatmentâ and patientâspecific data.
Results
Implant overall survival after 5âyears was 92.4% with an implant success rate of 74.9%. Main reasons for implant failure were marginal bone resorption (20.9%), implant not in situ or unloaded (9.6%) and periâimplantitis (7.5%). A mean radiation dose of 62.6 Gy was applied with a mean parotid dose of 35âGy. Modulating radiation techniques went along with lower grades of xerostomia (pâ50âGy (HR 7.9), parotid dose >30âGy (HR 2.3), bone (HR 14.5) and soft tissue (HR 4.5) transplants, bad oral hygiene (HR 3.8), nonmodulated radiation treatment planning (HR 14.5), and nontelescopic prosthetics (HR 5.2).
Conclusion
Radiotherapy impedes implant success in a doseâdependent manner at implant site. Modern radiation techniques effectively reduce xerostomia favoring implantâbased prosthetic rehabilitation. Implantation in bone grafts is more critical and telescopicâretained overdentures should be preferred
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
In any type of invasive surgery, the patientâs individual risk of thromboembolism has to be weighed against the risk of bleeding. Based on various everyday situations in clinical routine, the purpose of the present expert recommendations is to provide appropriate perioperative and periinterventional management for patients with atrial fibrillation undergoing long-term treatment with the thrombin inhibitor dabigatran. As we currently have no routine laboratory test to measure therapeutic levels of the substance or the risk of bleeding, general measures such as a standardized documentation of the patientâs history, a sufficient time interval between the last preoperative dose and the procedure, and careful control of local hemostasis should be given special attention
Correlations between Coronary Plaque Tissue Composition Assessed by Virtual Histology and Blood Levels of Biomarkers for Coronary Artery Disease
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
Hypertension is a risk factor for both progression of atrial fibrillation (AF) and development of AF-related complications, that is major adverse cardiac and cerebrovascular events (MACCE). It is unknown whether left ventricular hypertrophy (LVH) as a consequence of hypertension is also a risk factor for both these end points. We aimed to assess this in low-risk AF patients, also assessing gender-related differences. We included 799 patients from the Euro Heart Survey with nonvalvular AF and a baseline echocardiogram. Patients with and without hypertension were included. End points after 1 year were occurrence of AF progression, that is paroxysmal AF becoming persistent and/or permanent AF, and MACCE. Echocardiographic LVH was present in 33% of 379 hypertensive patients. AF progression after 1 year occurred in 10.2% of 373 patients with rhythm follow-up. In hypertensive patients with LVH, AF progression occurred more frequently as compared with hypertensive patients without LVH (23.3% vs 8.8%, pâŻ=âŻ0.011). In hypertensive AF patients, LVH was the most important multivariably adjusted determinant of AF progression on multivariable logistic regression (odds ratio 4.84, 95% confidence interval 1.70 to 13.78, pâŻ=âŻ0.003). This effect was only seen in male patients (27.5% vs 5.8%, pâŻ=âŻ0.002), while in female hypertensive patients, no differences were found in AF progression rates regarding the presence or absence of LVH (15.2% vs 15.0%, pâŻ=âŻ0.999). No differences were seen in MACCE for hypertensive patients with and without LVH. In conclusion, in men with hypertension, LVH is associated with AF progression. This association seems to be absent in hypertensive women
Bioimpedance cardiography in pregnancy: A longitudinal cohort study on hemodynamic pattern and outcome
Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis
Objectives: We investigated clinical correlates of atrial fibrillation (AF) progression and evaluated the prognosis of patients demonstrating AF progression in a large population. Background: Progression of paroxysmal AF to more sustained forms is frequently seen. However, not all patients will progress to persistent AF. Methods: We included 1,219 patients with paroxysmal AF who participated in the Euro Heart Survey on AF and had a known rhythm status at follow-up. Patients who experienced AF progression after 1 year of follow-up were identified. Results: Progression of AF occurred in 178 (15%) patients. Multivariate analysis showed that heart failure, age, previous transient ischemic attack or stroke, chronic obstructive pulmonary disease, and hypertension were the only independent predictors of AF progression. Using the regression coefficient as a benchmark, we calculated the HATCH score. Nearly 50% of the patients with a HATCH score >5 progressed to persistent AF compared with only 6% of the patients with a HATCH score of 0. During follow-up, patients with AF progression were more often admitted to the hospital and had more major adverse cardiovascular events. Conclusions: A substantial number of patients progress to sustained AF within 1 year. The clinical outcome of these patients regarding hospital admissions and major adverse cardiovascular events was worse compared with patients demonstrating no AF progression. Factors known to cause atrial structural remodeling (age and underlying heart disease) were independent predictors of AF progression. The HATCH score may help to identify patients who are likely to progress to sustained forms of AF in the near future. \ua9 2010 American College of Cardiology Foundation
- âŠ